Colon cancer is the third most common cancer and the third leading cause of cancer-related mortality in the United States. Approximately 10% of colorectal cancer develops within a small subset of serrated polyps, which is associated with the CpG Island Methylator Phenotype (CIMP). A number of genetic lesions have been associated with the serrated polyps, but the mechanisms that cause serrated adenomas and carcinomas to form are poorly understood. We have developed the first mouse model for serrated polyps. In HB28 mice, the combined expression of HB-EGF and an activated GPCR (US28) in the intestinal epithelium leads to development of lesions that share many morphological and biochemical similarities to the serrated polyps in humans. Strikingly, development of the serrated lesions appears to be dependent on both genetic and environmental factors. We hypothesize that the combined activity of HB-EGF and US28 induces disease development by up-regulating RAS/RAF signaling, which is seen in human serrated adenomas. We will directly test this hypothesis by comparing and contrasting HB28 mice with newly generated transgenic mice expressing activated Braf and Kras in the intestinal epithelium. Finally, we will determine if environmental factors such as microbes are required for development of serrated polyps. Together the studies outlined in this proposal should help define the molecular mechanisms accounting for development of serrated polyps.
Colon cancer is the third most common cancer and the third leading cause of cancer-related mortality in the United States. A significant proportion of colorectal cancer develops within a small subset of lesions called serrated lesions. We have generated genetically modified mice that develop such lesions. The study of this novel cancer model may contribute to a better understanding of the mechanisms leading to the formation of serrated lesions and hopefully to the development of new strategies for its prevention and treatment.
|Parkunan, Salai Madhumathi; Randall, C Blake; Astley, Roger A et al. (2016) CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection. J Leukoc Biol 100:1125-1134|
|Dong, Xiaonan; Cheng, Adam; Zou, Zhongju et al. (2016) Endolysosomal trafficking of viral G protein-coupled receptor functions in innate immunity and control of viral oncogenesis. Proc Natl Acad Sci U S A 113:2994-9|
|Lu, Geming; Zhang, Ruihua; Geng, Shuo et al. (2015) Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. Nat Commun 6:6676|
|Chen, Lili; He, Zhengxiang; Slinger, Erik et al. (2015) IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. Mucosal Immunol 8:390-402|
|Brix, Silke R; Stege, Gesa; Disteldorf, Erik et al. (2015) CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN. J Am Soc Nephrol 26:2105-17|
|Disteldorf, Erik M; Krebs, Christian F; Paust, Hans-Joachim et al. (2015) CXCL5 drives neutrophil recruitment in TH17-mediated GN. J Am Soc Nephrol 26:55-66|
|Berres, Marie-Luise; Lim, Karen Phaik Har; Peters, Tricia et al. (2014) BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 211:669-83|
|Noriega, Vanessa M; Gardner, Thomas J; Redmann, Veronika et al. (2014) Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination. Viruses 6:1202-18|
|Furtado, G C; Pacer, M E; Bongers, G et al. (2014) TNF?-dependent development of lymphoid tissue in the absence of ROR?t? lymphoid tissue inducer cells. Mucosal Immunol 7:602-14|
|Bongers, Gerold; Pacer, Michelle E; Geraldino, Thais H et al. (2014) Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med 211:457-72|
Showing the most recent 10 out of 15 publications